Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1344201

registered interest
date	06/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to (a) monitor covid-19 vaccination rates and (b) increase vaccine uptake among people who are homeless; if he will publish data to support vaccine uptake among homeless people; and if he will make a statement.
tabling member constituency	Brighton, Pavilion
tabling member printed	Caroline Lucas
uin	28141
answer	answer is ministerial correction date of answer 22/07/2021 answer text <p>People who are experiencing homelessness were prioritised for vaccination in phase one of the programme alongside those with underlying health conditions, as advised by the Joint Committee on Vaccination and Immunisation (JCVI). To ensure access, we have followed the JCVI recommendation that this group should be offered the vaccine without the need for a National Health Service number or general practitioner registration.</p><p>Vaccination rates amongst the homeless population is monitored at a regional level within England and is used to inform deployment decisions so that uptake is maximised where possible. Data on vaccination uptake is not currently available as it has not been centrally validated. This is because data provides a snapshot of homelessness rates and as such, any vaccine uptake data relating to homeless people and COVID-19 vaccination uptake is also an estimate that cannot currently be validated. NHS England and NHS Improvement continue to work with the Ministry of Housing, Communities and Local Government to support outreach services and further work is being done to explore the availability of effective on-street models. Local vaccination services also play a vital role in reaching vulnerable groups, including people experiencing homelessness.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 28237 question first answered 22/07/2021 14:28:05 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	3930 label Biography information for Caroline Lucas

1344217

registered interest
date	06/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that covid-19 vaccination uptake among people who are homeless is in line with uptake among the general population.
tabling member constituency	Lancaster and Fleetwood
tabling member printed	Cat Smith
uin	28237
answer	answer is ministerial correction date of answer 22/07/2021 answer text <p>People who are experiencing homelessness were prioritised for vaccination in phase one of the programme alongside those with underlying health conditions, as advised by the Joint Committee on Vaccination and Immunisation (JCVI). To ensure access, we have followed the JCVI recommendation that this group should be offered the vaccine without the need for a National Health Service number or general practitioner registration.</p><p>Vaccination rates amongst the homeless population is monitored at a regional level within England and is used to inform deployment decisions so that uptake is maximised where possible. Data on vaccination uptake is not currently available as it has not been centrally validated. This is because data provides a snapshot of homelessness rates and as such, any vaccine uptake data relating to homeless people and COVID-19 vaccination uptake is also an estimate that cannot currently be validated. NHS England and NHS Improvement continue to work with the Ministry of Housing, Communities and Local Government to support outreach services and further work is being done to explore the availability of effective on-street models. Local vaccination services also play a vital role in reaching vulnerable groups, including people experiencing homelessness.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 28141 question first answered 22/07/2021 14:28:05 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4436 label Biography information for Cat Smith

1344218

registered interest
date	06/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether it is his policy that people who are homeless will be a priority group within the covid-19 booster vaccination programme.
tabling member constituency	Lancaster and Fleetwood
tabling member printed	Cat Smith
uin	28238
answer	answer is ministerial correction date of answer 14/07/2021 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI) published interim advice on a potential COVID-19 booster vaccination programme on 30 June, which is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022" target="_blank">https://www.gov.uk/government/publications/jcvi-interim-advice-on-a-potential-coronavirus-covid-19-booster-vaccine-programme-for-winter-2021-to-2022</a></p><p>However, based on the JCVI’s interim advice, those eligible for phase one of the COVID-19 vaccination programme are likely to be offered a booster, including people experiencing homelessness and rough sleeping. Decisions on the timing, scope and cohort eligibility of any booster programme will be confirmed once the JCVI has provided their final advice.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 14/07/2021 16:48:02 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4436 label Biography information for Cat Smith

1344239

registered interest
date	06/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS Covid Pass: Clinical Trials
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans his Department has to help ensure that people who took part in covid-19 vaccination trials are able to correctly log their vaccine doses on their medical records for the purposes of foreign travel.
tabling member constituency	Southport
tabling member printed	Damien Moore
uin	28311
answer	answer is ministerial correction date of answer 14/07/2021 answer text <p>The Government is working with clinical research sites to add participant information of COVID-19 vaccine clinical trials into the National Immunisation Management Service (NIMS), in order to allow participants to access their COVID Pass for events and travel purposes.</p><p>Participants of trials which have been unblinded, including those who received unlicensed vaccines, will be able to obtain a COVID Pass for international travel based on their vaccination status, with details of their vaccine records accessible within their COVID Pass, once these are available on NIMS.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 14/07/2021 11:39:48 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4669 label Biography information for Damien Moore

1344252

registered interest
date	06/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus Certificates
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department has taken to ensure that people who have been vaccinated against covid-19 with the AstraZeneca vaccine batches produced in India are able to travel to Europe under the digital covid certificate scheme.
tabling member constituency	Romford
tabling member printed	Andrew Rosindell
uin	28108
answer	answer is ministerial correction date of answer 14/07/2021 answer text <p>The Government continues to engage with the European Union on certification to ensure that travel between the United Kingdom and the EU is supported by a common approach.</p><p>The Serum Institute of India (SII) manufactures Vaxzevria and Covishield and both branded vaccines are the same as the University of Oxford/AstraZeneca vaccine. All SII-made doses approved by the UK regulator, the Medicines and Healthcare products Regulatory Agency (MHRA) and administered in the UK were branded as the ’COVID-19 vaccine AstraZeneca’ which is now known commercially as ‘Vaxzevria’. The MHRA has not approved doses branded as ‘Covishield’ and none have been administered in the UK. All AstraZeneca vaccines given in the UK are the same product and appear on the NHS COVID Pass as Vaxzevria. The European Medicines Agency has authorised the Vaxzevria vaccine and it is therefore recognised by the EU.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 14/07/2021 16:13:40 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1447 label Biography information for Andrew Rosindell

1344256

registered interest
date	06/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department has taken to ensure long-term monitoring of the immune response among people who have received different covid-19 vaccines for each dose.
tabling member constituency	Romford
tabling member printed	Andrew Rosindell
uin	28110
answer	answer is ministerial correction date of answer 14/07/2021 answer text <p>The National Institute for Health Research has commissioned the National Immunisation Schedule Evaluation Consortium to undertake the Com-CoV trial. This trial is gathering data on the long-term immune response of using different COVID-19 vaccines for the first and second dose. Public Health England has also undertaken follow up on people given mixed schedules as part of routine care to monitor self-reported side effects and antibody response. The results will be published in due course.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 14/07/2021 11:36:55 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1447 label Biography information for Andrew Rosindell

1344258

registered interest
date	06/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department plans to take to ensure long-term monitoring of the immune response among people given a covid-19 vaccine booster in autumn 2021.
tabling member constituency	Romford
tabling member printed	Andrew Rosindell
uin	28111
answer	answer is ministerial correction date of answer 14/07/2021 answer text <p>The Joint Committee on Vaccination and Immunisation has made interim recommendations on the potential COVID-19 vaccine booster programme. Should this be confirmed, plans to evaluate the programme will be developed in due course.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 14/07/2021 16:40:34 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1447 label Biography information for Andrew Rosindell

1344259

registered interest
date	06/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Influenza
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the implications for its policies of reported anticipated higher number of flu cases in the winter of 2021.
tabling member constituency	Romford
tabling member printed	Andrew Rosindell
uin	28112
answer	answer is ministerial correction date of answer 14/07/2021 answer text <p>Public Health England will continue to monitor flu activity each week and identify any unexpected changes. We are delivering an expanded flu vaccination programme this winter. This includes a continued offer of vaccination for 50 to 64 year olds and the children’s programme.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 14/07/2021 16:50:46 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	1447 label Biography information for Andrew Rosindell

1344378

registered interest
date	06/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that people participating in the Novavax vaccine trials are not disadvantaged by national and international vaccine certification policies.
tabling member constituency	Battersea
tabling member printed	Marsha De Cordova
uin	28325
answer	answer is ministerial correction date of answer 13/07/2021 answer text <p>The Government is working with clinical research sites to add participant information of COVID-19 vaccine clinical trials to the National Immunisation Management Service, in order to allow participants to access their Covid Pass for both domestic and international travel purposes.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 28326 question first answered 13/07/2021 15:29:11 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4676 label Biography information for Marsha De Cordova

1344379

registered interest
date	06/07/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS Covid Pass: Clinical Trials
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department has taken to ensure that people participating in the Novavax vaccine trials are (a) able to show proof of their vaccine status for international travel and (b) not placed at a disadvantage when travelling overseas.
tabling member constituency	Battersea
tabling member printed	Marsha De Cordova
uin	28326
answer	answer is ministerial correction date of answer 13/07/2021 answer text <p>The Government is working with clinical research sites to add participant information of COVID-19 vaccine clinical trials to the National Immunisation Management Service, in order to allow participants to access their Covid Pass for both domestic and international travel purposes.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi grouped question UIN 28325 question first answered 13/07/2021 15:29:11 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	4676 label Biography information for Marsha De Cordova